The hallmark of this innovative multiple sclerosis treatment center is its multidisciplinary approach to MS care and research. A broad base of talented physicians, scientists, and medical specialists are committed to understanding the cause, and overcoming the consequences, of this devastating condition.

Through this synergistic approach, The Corinne Goldsmith Dickinson (CGD) Center for Multiple Sclerosis at Mount Sinai Medical Center holds the promise of tremendous progress for MS patients-offering the best care available today and hope for better therapies and a cure tomorrow.

About the Corinne Goldsmith Dickinson Center for Multiple Sclerosis

Based in New York City, the Corinne Goldsmith Dickinson Center for MS provides a comprehensive approach to disease management, including state-of-the-art programs in diagnostics, experimental therapeutics, basic and clinical research, and support services.

The CGD Center has assembled the finest clinical and scientific expertise in the field of MS and related disciplines, under the leadership of Director Fred D. Lublin, M.D. An international authority on the clinical and scientific aspects of MS, Dr. Lublin is recognized as one of the foremost experts in experimental therapies.

Aaron E. Miller, M.D., Medical Director, is internationally-recognized as a preeminent MS clinician. He is also a principal investigator in several clinical trials of new medications conducted at the Center.

From a single location, the Center offers the coordination of all aspects of patient care including diagnosis, disease management, rehabilitation, and support services. Because the Center is devoted to enhancing quality of life for MS sufferers, patients have access to the latest and most promising research advances, and the opportunity to participate in trials of new therapeutic agents not widely available.